C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 19/167 (2006.01) A61K 31/70 (2006.01) C07H 19/16 (2006.01)
Patent
CA 2490253
The present invention relates to compounds according to the general formula (I), wherein R1, A, B, Q, T, W and X have the meanings given in the description. These compounds are useful for the manufacture of a medicament for the treatment of insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders or cardiovasular disease or for providing an anti-lipolytic effect.
L'invention porte sur des composés de formule générale (I) dans laquelle: R?1¿, A, B, Q, T, W et X ont les significations données dans la description. Ces composés s'avèrent utiles pour l'élaboration de médicaments: traitant la résistance à l'insuline, le diabète de type 2, les syndromes du métabolisme, les troubles lipidiques, ou les maladies cardio-vasculaires, ou à action anti-lipolytique.
Bigot Antony
Herling Andreas
Hock Franz Jakob
Jaehne Gerhard
Mueller Guenter
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Novel adenosine analogues and their use as pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel adenosine analogues and their use as pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel adenosine analogues and their use as pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1948654